Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THR-18 with tPA in Acute Ischemic Stroke
NCT01957774Phase 2Completed
- Sponsor
- D-Pharm
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of THR-18 in ischemic stroke, sponsored by D-Pharm. Started Oct 2013; status: completed.
02
Drugs
THR-18
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01957774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957774.